XTL Biopharmaceuticals Ltd.

The momentum for this stock is not very good. Tradey thinks it is not wise to invest in XTL Biopharmaceuticals Ltd..

XTL Biopharmaceuticals Ltd is a biopharmaceutical company, which engages in the acquisition and deve...

News

XTL Biopharmaceuticals completes acquisition of The Social Proxy

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

XTL Completed the Acquisition of The Social Proxy and a Private Placement of $1.5 Million

Globe Newswire expands its IP portfolio to AI Web Data The Social Proxy is a web data AI company developing and powering an IP based platform for AI & BI Applications at scale Completed a Private Placement...\n more…

XTL Entered Definitive Agreement to Acquire The Social Proxy

Globe Newswire expands its IP portfolio to AI Web Data The Social Proxy is a web data AI company developing and powering an IP based platform for AI & BI Applications at scale Secured $1.5 Million in a...\n more…

12 titoli sanitari in movimento, pre-market del 18/03/2024

Benzinga Titoli in rialzo Le azioni di XTL Biopharmaceuticals (NASDAQ:XTLB) hanno fatto segnare +19,31% a 1,05 dollari durante la sessione pre-market di lunedì. Il titolo 2seventy bio (NASDAQ:TSVT) è salito del 18,45% a 4,75\n more…

XTL Biopharmaceuticals discloses Nasdaq listing deficiency notice

XTL Biopharmaceuticals Confirms that it has not Experienced any Disruption to its Business Operations in Israel

Globe Newswire Ramat Gan, Israel, Oct. 20, 2023 (GLOBE NEWSWIRE) -- XTL Biopharmaceuticals Ltd. (Nasdaq: XTLB, TASE: XTLB.TA) ("XTL" or the "Company"), a clinical stage biopharmaceutical company whose main...\n more…